Not provided
Not provided
Not provided
Not provided
Not provided
Study was not funded and pilot work proved impractical.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study examines whether isolated doses of D-cycloserine enhance the efficacy of CBT for smoking cessation.
In comparison to placebo-augmented cognitive behavioral therapy (CBT), D-cycloserine-augmented CBT will lead to a greater reduction in both short-and long-term point prevalence abstinence as well as time to first smoking lapse and time to smoking relapse.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 | Experimental | DCS-augmented CBT for smoking cessation |
|
| 2 | Placebo Comparator | Placebo-augmented CBT for smoking cessation |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| D-cycloserine | Drug | Single dosage prior to sessions 3, 4 & 5 |
|
|
| Measure | Description | Time Frame |
|---|---|---|
| Carbon monoxide analysis | Baseline, Weeks 4, 5, 6, 7, 8, 9, 13, 21, & 29 | |
| Cotinine levels in saliva | Baseline, Weeks 21 & 29 |
| Measure | Description | Time Frame |
|---|---|---|
| Anxiety Sensitivity Index | Baseline, Weeks 5, 6, 7, 8, 9, 13, 21 & 29 | |
| Minnesota Withdrawal Scale | Each visit | |
| Mood & Anxiety Symptom Questionnaire |
Not provided
Inclusion Criteria:
1. Be a regular smoker for at least one year 3. Currently smoke an average of at least 10 cigarettes per day 4. Report a motivation to quit smoking in the next month of at least 5 on a 10 point scale 5. Score 20 or greater on the 16-item Anxiety Sensitivity Index (Schmidt & Joiner, 2002).
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Boston University | Boston | Massachusetts | 02215 | United States |
Not provided
| ID | Term |
|---|---|
| D012907 | Smoking |
| ID | Term |
|---|---|
| D001519 | Behavior |
Not provided
Not provided
| ID | Term |
|---|---|
| D003523 | Cycloserine |
| ID | Term |
|---|---|
| D007555 | Isoxazoles |
| D001393 | Azoles |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Placebo | Drug | Single dosage prior to sessions 3, 4 & 5 |
|
| Baseline, Weeks 1, 2, 3, 4, 5, 6, 7, & 8 |
| Smoking Cessation Self-Efficacy | Baseline, Weeks 3, 4, 5, 6, 7, 8, 9, 13, 21 & 29 |
| D023303 |
| Oxazolidinones |
| D010080 | Oxazoles |
| D012694 | Serine |
| D021542 | Amino Acids, Neutral |
| D000596 | Amino Acids |
| D000602 | Amino Acids, Peptides, and Proteins |